Medicinal Product Shortages - update - 03 July 2024

Notice type: Advisory

Date: 03/07/2024

This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.

We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.

Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.

Resolved shortages

The following shortages have been resolved and supply has resumed to the Irish market:

Product

Active Ingredient(s)

Clarithromycin 250mg Film Coated Tablets

PA2050/002/001

Sun Pharmaceutical Industries Europe B.V

Clarithromycin

Tyvense 60mg Capsules

PA23211/005/005

Takeda Pharmaceuticals International AG Ireland Branch

Lisdexamfetamine

Omesar 40mg Film Coated Tablets

PA0865/011/003

Menarini International Operations Luxembourg S.A.

Olmesartan 

Newly notified shortages

The HPRA has been notified of a shortage of the following products:

Product

Active Ingredient(s)

Candesartan 4mg Tablets

PA2315/150/001

Accord Healthcare Ireland Ltd.

Candesartan

Candist 4mg Tablets

PA0126/206/001

Clonmel Healthcare Ltd

Candesartan

Nyxoid Nasal spray, solution in single-dose container

EU/1/17/1238/001

Mundipharma Corporation (Ireland) Limited

Naloxone

Palmeux 75mg prolonged-release suspension for injection in pre-filled syringe

PA1142/040/003

Amdipharm Limited

Paliperidone

Palmeux 150mg prolonged-release suspension for injection in pre-filled syringe

PA1142/040/005

Amdipharm Limited

Paliperidone

Temozolomide Teva 100mg Capsules

EU/1/09/606/005-006

Teva B.V.

Temozolomide

Please see the shortages section of the HPRA website for further information

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.



« Back